GoAI
Get started
Good Fellow Healthcare Holdings Limited logo

Good Fellow Healthcare Holdings Limited

8143.HK

HKSEHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

HK$0.061

HK$0.00 · 0.00%

Aug 21, 2:56 PM HKT

8143.HK company overview

Historical prices · Market data may be delayed.

Company profile

Company website

Good Fellow Healthcare Holdings Limited, an investment holding entity based in Central, Hong Kong, offers a range of general hospital services both within the People's Republic of China and globally. These services feature medical and surgical inpatient care, alongside health check-ups and diagnostic examinations. As of March 31, 2022, the company oversaw two general hospitals, situated in Putain and Beijing. Furthermore, it engages in medical investment, hospital administration, and consulting management services. Established in 2001, the company rebranded to its current name in February 2019, having previously operated as Hua Xia Healthcare Holdings Limited. It functions as a subsidiary of Solar Star Global Limited.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
HK
CEO
Chi Lung Ng
Listed since
May 10, 2002
Employees
28

Market position

52-week range

Current HK$0.061

Open
HK$0.061
Previous close
HK$0.061
Volume
40K
0.36× average
Average volume
110.17K
Average daily volume
Market cap
13.75M HKD
Beta
0.6
Market reference 1
50-day average
HK$0.0656
-6.96% below average
200-day average
HK$0.1182
-48.41% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
-0.79×
P/B (TTM)
1.7×
P/S (TTM)
0.55×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
42.68%
Operating margin
-71.34%
Net margin
-70.25%

Financial health

Debt / equity
0.06×
Altman Z-score
0.94
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends65%17%-30%-77%Gross margin, FY2021: 49.15%Gross margin, FY2022: 48.79%Gross margin, FY2023: 47.93%Gross margin, FY2024: 51.92%Gross margin, FY2025: 52.85%Operating margin, FY2021: -10.86%Operating margin, FY2022: -9.46%Operating margin, FY2023: -41.16%Operating margin, FY2024: -44.53%Operating margin, FY2025: -65.64%Net margin, FY2021: -23.40%Net margin, FY2022: -10.62%Net margin, FY2023: -43.91%Net margin, FY2024: -62.82%Net margin, FY2025: -62.43%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 49.15%. Gross margin FY2022 48.79%. Gross margin FY2023 47.93%. Gross margin FY2024 51.92%. Gross margin FY2025 52.85%. Operating margin FY2021 -10.86%. Operating margin FY2022 -9.46%. Operating margin FY2023 -41.16%. Operating margin FY2024 -44.53%. Operating margin FY2025 -65.64%. Net margin FY2021 -23.40%. Net margin FY2022 -10.62%. Net margin FY2023 -43.91%. Net margin FY2024 -62.82%. Net margin FY2025 -62.43%.

Income trends

Revenue

20.06M HKD+24.44%

Operating income

−13.17M HKD-83.45%

Net income

−12.52M HKD-23.66%
Income trends across reported periods62.6M HKD33.61M HKD4.63M HKD−24.36M HKDRevenue, FY2021: 54.24M HKDRevenue, FY2022: 55.35M HKDRevenue, FY2023: 38.96M HKDRevenue, FY2024: 16.12M HKDRevenue, FY2025: 20.06M HKDOperating income, FY2021: −5.89M HKDOperating income, FY2022: −5.24M HKDOperating income, FY2023: −16.04M HKDOperating income, FY2024: −7.18M HKDOperating income, FY2025: −13.17M HKDNet income, FY2021: −12.69M HKDNet income, FY2022: −5.88M HKDNet income, FY2023: −17.11M HKDNet income, FY2024: −10.13M HKDNet income, FY2025: −12.52M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 54.24M HKD. Revenue FY2022 55.35M HKD. Revenue FY2023 38.96M HKD. Revenue FY2024 16.12M HKD. Revenue FY2025 20.06M HKD. Operating income FY2021 −5.89M HKD. Operating income FY2022 −5.24M HKD. Operating income FY2023 −16.04M HKD. Operating income FY2024 −7.18M HKD. Operating income FY2025 −13.17M HKD. Net income FY2021 −12.69M HKD. Net income FY2022 −5.88M HKD. Net income FY2023 −17.11M HKD. Net income FY2024 −10.13M HKD. Net income FY2025 −12.52M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue20.06M HKD16.12M HKD38.96M HKD55.35M HKD54.24M HKD
Cost of goods sold9.46M HKD7.75M HKD20.29M HKD28.34M HKD27.58M HKD
Gross profit10.6M HKD8.37M HKD18.67M HKD27.01M HKD26.66M HKD
Selling, general, and administrative16.97M HKD18.17M HKD29.19M HKD37.31M HKD62.35M HKD
Operating expenses23.77M HKD15.55M HKD34.71M HKD32.27M HKD32.55M HKD
Interest income6K HKD1K HKD28K HKD448K HKD364K HKD
Interest expense152K HKD190K HKD308K HKD414K HKD1.66M HKD
Depreciation and amortization6.93M HKD9.04M HKD5.92M HKD7.06M HKD10.27M HKD
Operating income−13.17M HKD−7.18M HKD−16.04M HKD−5.24M HKD−5.89M HKD
Net income−12.52M HKD−10.13M HKD−17.11M HKD−5.88M HKD−12.69M HKD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-0.08

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.070.01-0.05-0.12Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q4 '24Q1 '25
Q1 2023, reported Feb 8, 2023: actual -0.006, estimate —, surprise —, Comparison unavailable. Q2 2023, reported Jun 16, 2023: actual 0.007, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 8, 2023: actual -0.034, estimate —, surprise —, Comparison unavailable. Q4 2023, reported Nov 7, 2023: actual -0.03, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Feb 12, 2024: actual -0.043, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Jun 28, 2024: actual -0.043, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Nov 8, 2024: actual 0.033, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 7, 2025: actual -0.076, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates15.29M11M6.71M2.42MQ1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q4 '24Q1 '25
Q1 2023, reported Feb 8, 2023: actual 12.58M HKD, estimate —, surprise —, Comparison unavailable. Q2 2023, reported Jun 16, 2023: actual 14.37M HKD, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 8, 2023: actual 13.93M HKD, estimate —, surprise —, Comparison unavailable. Q4 2023, reported Nov 7, 2023: actual 12.2M HKD, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Feb 12, 2024: actual 6.42M HKD, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Jun 28, 2024: actual 6.42M HKD, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Nov 8, 2024: actual 5.22M HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 7, 2025: actual 2.84M HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Corporate action history

Stock split

Effective Jun 24, 2026

1:5

Stock split

Effective Sep 13, 2023

1:5

Stock split

Effective Dec 10, 2010

1:10

Stock split

Effective May 12, 2005

1:5

8143.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$197.4

-4.08%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.30

-3.94%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$221.8

-2.72%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$48.54

-4.82%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.14

-5.86%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$100.5

-1.86%

Continue in GoAI

Research 8143.HK

research.disclaimer